News 2026.01.13

NeuroXess Breaks Ground on “Super-factory” in Ganjiang New District, Marking a Major Leap in BCI Industrialization

[Nanchang, Jiangxi, January 2026] Today, NeuroXess, a domestic leader in implantable flexible brain-computer interfaces (BCIs), held a groundbreaking ceremony in Ganjiang New District, Jiangxi Province, for its “Super-factory” project. Serving as the primary physical hub for NeuroXess’s dual-core strategy of “R&D in Shanghai, Manufacturing in Jiangxi” and creating a complete BCI industrial closed loop, this facility marks a pivotal step for China in transitioning from laboratory research to scaled mass production within this frontier domain. Furthermore, it assumes the manufacturing mission for China’s first and the world’s second “Triple-F” (Fully-implanted, Fully-wireless, and Fully-functional) BCI system, carrying forward the development of an integrated BCI and artificial intelligence ecosystem. The Giga-factory stands as NeuroXess’s strategic linchpin bridging “scientific breakthroughs in Shanghai” with “manufacturing execution in Jiangxi.” The facility is slated for completion and operation in the second half of 2026,accompanied by an official inauguration ceremony.

 

New 0113

Schematic Rendering of the “Super-factory” Project

 

At the groundbreaking ceremony, Dr. Tiger  H. Tao, Founder and Chief Scientist of NeuroXess, stated: “Today, we are laying the foundation not merely for a manufacturing plant, but for an industrial path where ‘technology benefits life.’ This Super-factory is the cornerstone of our commitment to ‘Tech for Good’ and a central hub for building a collaborative ecosystem across the BCI industry.” Since its planning stages, the project has received strong attention and robust support from the Jiangxi Provincial Party Committee, the Jiangxi Provincial People’s Government, the Jiangxi Provincial Department of Science and Technology, the Ganjiang New District Administrative Committee, and related functional agencies, creating an accelerated pathway “from 1 to 100” for translating cutting-edge technology into industrial reality.

 

“Three Cores in One”: Establishing Core Industrialization Capabilities

 

New 0113

Master Plan of the “Super-factory” Industrial Campus

 

The first phase of the “Super-factory” covers a planned construction area of approximately 14,300 square meters, supporting three strategic core functions:

 

As a “Super Production Base”: Leveraging Jiangxi’s solid industrial foundation and manufacturing capabilities, the plant will focus on the scaled, standardized production of NeuroXess’s proprietary high-throughput implantable flexible electrodes, high-frequency EEG devices, surgical implantation robots, and particularly China’s first and the world’s second “Triple-F” (Fully-implanted, Fully-wireless, and Fully-functional) BCI system. Aiming for stable annual delivery capacities of tens of thousands of units, the facility is designed to transform BCI hardware from custom laboratory builds into widely accessible solutions.

 

As a “Super Data Center”: The facility will function as an “intelligent brain” driving continuous technical iteration, establishing a professional center for neural signal collection, processing, and analysis. By leveraging data to refine algorithms and guide next-generation R&D, it aims to foster an industrial ecosystem where BCI and artificial intelligence deeply converge.

 

As a “Life Simulation Rehabilitation Zone”: The facility features an innovative, all-in-one rehabilitation training environment that mirrors real-world living and working scenarios. This setup aims to help patients with BCI implants rebuild essential life skills efficiently, enabling them to reintegrate into society with dignity.

 

Strengthening Full-Stack Capabilities, Leading Industrial Ecosystem Aggregation

 

As the only BCI company globally to simultaneously achieve real-time Mandarin speech and motor decoding, NeuroXess has established proprietary, full-stack R&D capabilities spanning flexible electrodes, neural chips, implants, surgical robots, and BCI operating systems. Beyond conducting over 50 clinical trials in top tertiary hospitals like Huashan Hospital—securing milestones such as the world’s first real-time Mandarin speech decoding and China’s first clinical success with a “Triple-F” BCI—the company serves more than 70 top-tier research and medical institutions nationwide, holding a leading position in China’s domestic BCI scientific equipment market.

 

The development of this Super-factory provides a direct industrial outlet for the company’s technical foundations. Functioning as an attractive magnet, the facility will coordinate with upstream and downstream supply chain partners to establish a comprehensive industrial matrix across core components, R&D services, and clinical applications in Ganjiang New District, accelerating the formation of a globally competitive BCI industrial cluster.

 

Outlook: From Groundbreaking to Inauguration, Opening a New Industrial Chapter

 

With the successful conclusion of the groundbreaking ceremony, the NeuroXess Super-factory project transitions into full-scale construction. Looking ahead to the second half of 2026, when this modern industrial hub is formally inaugurated, it will realize the scaled manufacturing and dependable delivery of China’s high-performance “Triple-F” BCI systems. Beginning in 2026, what journeys out to the world from here will be thousands of opportunities for individuals to reclaim their lives.

 

The future of brain-computer interfaces demands both visionary scientific breakthroughs and grounded manufacturing capabilities. From today’s groundbreaking to future mass production, NeuroXess is advancing with steady steps along the path of industrialization, turning the vision of “connecting life and hope” into a broader reality.